King's College London

Research portal

Long-term benefits of digital cognitive behavioural therapy for insomnia: Follow-up report from a randomized clinical trial

Research output: Contribution to journalArticle

Standard

Long-term benefits of digital cognitive behavioural therapy for insomnia : Follow-up report from a randomized clinical trial. / Luik, Annemarie I; Marsden, Antonia; Emsley, Richard; Henry, Alasdair L; Stott, Richard; Miller, Christopher B; Espie, Colin A.

In: Journal of Sleep Research, 28.02.2020, p. e13018.

Research output: Contribution to journalArticle

Harvard

Luik, AI, Marsden, A, Emsley, R, Henry, AL, Stott, R, Miller, CB & Espie, CA 2020, 'Long-term benefits of digital cognitive behavioural therapy for insomnia: Follow-up report from a randomized clinical trial', Journal of Sleep Research, pp. e13018. https://doi.org/10.1111/jsr.13018

APA

Luik, A. I., Marsden, A., Emsley, R., Henry, A. L., Stott, R., Miller, C. B., & Espie, C. A. (2020). Long-term benefits of digital cognitive behavioural therapy for insomnia: Follow-up report from a randomized clinical trial. Journal of Sleep Research, e13018. https://doi.org/10.1111/jsr.13018

Vancouver

Luik AI, Marsden A, Emsley R, Henry AL, Stott R, Miller CB et al. Long-term benefits of digital cognitive behavioural therapy for insomnia: Follow-up report from a randomized clinical trial. Journal of Sleep Research. 2020 Feb 28;e13018. https://doi.org/10.1111/jsr.13018

Author

Luik, Annemarie I ; Marsden, Antonia ; Emsley, Richard ; Henry, Alasdair L ; Stott, Richard ; Miller, Christopher B ; Espie, Colin A. / Long-term benefits of digital cognitive behavioural therapy for insomnia : Follow-up report from a randomized clinical trial. In: Journal of Sleep Research. 2020 ; pp. e13018.

Bibtex Download

@article{87d52569b9464cf39c044b1ae3ca5ffb,
title = "Long-term benefits of digital cognitive behavioural therapy for insomnia: Follow-up report from a randomized clinical trial",
abstract = "Digital cognitive behavioural therapy (dCBT) is an effective treatment for chronic insomnia and also improves well-being and quality of life (QoL). We assessed whether these benefits are sustained and if the effects of dCBT extend to the use of sleep medication and healthcare. In total 1,711 adults (48.0 ± 13.8 years, 77.6{\%} female) with complaints of chronic insomnia participated in a previously published randomized controlled trial (ISRCTN 60530898) comparing dCBT (n = 853) with sleep hygiene education (SHE, n = 858). At weeks 0, 4, 8, 24, 36 and 48, we assessed functional health (Patient-Reported Outcomes Measurement Information System: Global Health Scale); psychological well-being (Warwick-Edinburgh Mental Well-being Scale) and sleep-related QoL (Glasgow Sleep Impact Index), prescribed and non-prescribed sleep medication use, and healthcare utilization. At week 25, those who received SHE at baseline were offered dCBT. dCBT improved functional health (difference: 2.45, 95{\%} confidence interval [CI]: 2.03; 2.88, Cohen's d: 0.50, p < .001), psychological well-being (difference: 4.34, 95{\%} CI: 3.70; 4.98, Cohen's d: 0.55, p < .001) and sleep-related QoL (difference: -44.61, 95{\%}CI: -47.17; -42.05, Cohen's d: -1.44, p < .001) at week 48 compared to baseline. At week 24 dCBT, compared to SHE, also reduced use of prescription and non-prescription sleep medication up to week 24 (adjusted rate ratio [RR]: 0.64, 95{\%} CI: 0.42; 0.97, p = .037 and adjusted RR: 0.52, 95{\%} CI: 0.37; 0.74, p < .0001, respectively), but not healthcare utilization. Uncontrolled follow-up suggests that these effects were sustained for non-prescribed sleep medication (RR: 0.52, 95{\%} CI: 0.40; 0.67, p < .001). In conclusion, this study suggests that dCBT results in sustained benefits to insomnia and its daytime outcomes.",
keywords = "cognitive behavioural therapy, healthcare usage, online, quality of life, sleep, sleep medication, well-being",
author = "Luik, {Annemarie I} and Antonia Marsden and Richard Emsley and Henry, {Alasdair L} and Richard Stott and Miller, {Christopher B} and Espie, {Colin A}",
note = "{\circledC} 2020 European Sleep Research Society.",
year = "2020",
month = "2",
day = "28",
doi = "10.1111/jsr.13018",
language = "English",
pages = "e13018",
journal = "Journal of Sleep Research",
issn = "0962-1105",
publisher = "Wiley-Blackwell",

}

RIS (suitable for import to EndNote) Download

TY - JOUR

T1 - Long-term benefits of digital cognitive behavioural therapy for insomnia

T2 - Follow-up report from a randomized clinical trial

AU - Luik, Annemarie I

AU - Marsden, Antonia

AU - Emsley, Richard

AU - Henry, Alasdair L

AU - Stott, Richard

AU - Miller, Christopher B

AU - Espie, Colin A

N1 - © 2020 European Sleep Research Society.

PY - 2020/2/28

Y1 - 2020/2/28

N2 - Digital cognitive behavioural therapy (dCBT) is an effective treatment for chronic insomnia and also improves well-being and quality of life (QoL). We assessed whether these benefits are sustained and if the effects of dCBT extend to the use of sleep medication and healthcare. In total 1,711 adults (48.0 ± 13.8 years, 77.6% female) with complaints of chronic insomnia participated in a previously published randomized controlled trial (ISRCTN 60530898) comparing dCBT (n = 853) with sleep hygiene education (SHE, n = 858). At weeks 0, 4, 8, 24, 36 and 48, we assessed functional health (Patient-Reported Outcomes Measurement Information System: Global Health Scale); psychological well-being (Warwick-Edinburgh Mental Well-being Scale) and sleep-related QoL (Glasgow Sleep Impact Index), prescribed and non-prescribed sleep medication use, and healthcare utilization. At week 25, those who received SHE at baseline were offered dCBT. dCBT improved functional health (difference: 2.45, 95% confidence interval [CI]: 2.03; 2.88, Cohen's d: 0.50, p < .001), psychological well-being (difference: 4.34, 95% CI: 3.70; 4.98, Cohen's d: 0.55, p < .001) and sleep-related QoL (difference: -44.61, 95%CI: -47.17; -42.05, Cohen's d: -1.44, p < .001) at week 48 compared to baseline. At week 24 dCBT, compared to SHE, also reduced use of prescription and non-prescription sleep medication up to week 24 (adjusted rate ratio [RR]: 0.64, 95% CI: 0.42; 0.97, p = .037 and adjusted RR: 0.52, 95% CI: 0.37; 0.74, p < .0001, respectively), but not healthcare utilization. Uncontrolled follow-up suggests that these effects were sustained for non-prescribed sleep medication (RR: 0.52, 95% CI: 0.40; 0.67, p < .001). In conclusion, this study suggests that dCBT results in sustained benefits to insomnia and its daytime outcomes.

AB - Digital cognitive behavioural therapy (dCBT) is an effective treatment for chronic insomnia and also improves well-being and quality of life (QoL). We assessed whether these benefits are sustained and if the effects of dCBT extend to the use of sleep medication and healthcare. In total 1,711 adults (48.0 ± 13.8 years, 77.6% female) with complaints of chronic insomnia participated in a previously published randomized controlled trial (ISRCTN 60530898) comparing dCBT (n = 853) with sleep hygiene education (SHE, n = 858). At weeks 0, 4, 8, 24, 36 and 48, we assessed functional health (Patient-Reported Outcomes Measurement Information System: Global Health Scale); psychological well-being (Warwick-Edinburgh Mental Well-being Scale) and sleep-related QoL (Glasgow Sleep Impact Index), prescribed and non-prescribed sleep medication use, and healthcare utilization. At week 25, those who received SHE at baseline were offered dCBT. dCBT improved functional health (difference: 2.45, 95% confidence interval [CI]: 2.03; 2.88, Cohen's d: 0.50, p < .001), psychological well-being (difference: 4.34, 95% CI: 3.70; 4.98, Cohen's d: 0.55, p < .001) and sleep-related QoL (difference: -44.61, 95%CI: -47.17; -42.05, Cohen's d: -1.44, p < .001) at week 48 compared to baseline. At week 24 dCBT, compared to SHE, also reduced use of prescription and non-prescription sleep medication up to week 24 (adjusted rate ratio [RR]: 0.64, 95% CI: 0.42; 0.97, p = .037 and adjusted RR: 0.52, 95% CI: 0.37; 0.74, p < .0001, respectively), but not healthcare utilization. Uncontrolled follow-up suggests that these effects were sustained for non-prescribed sleep medication (RR: 0.52, 95% CI: 0.40; 0.67, p < .001). In conclusion, this study suggests that dCBT results in sustained benefits to insomnia and its daytime outcomes.

KW - cognitive behavioural therapy

KW - healthcare usage

KW - online

KW - quality of life

KW - sleep

KW - sleep medication

KW - well-being

UR - http://www.scopus.com/inward/record.url?scp=85081031296&partnerID=8YFLogxK

U2 - 10.1111/jsr.13018

DO - 10.1111/jsr.13018

M3 - Article

C2 - 32112507

SP - e13018

JO - Journal of Sleep Research

JF - Journal of Sleep Research

SN - 0962-1105

ER -

View graph of relations

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454